Cover Image


Global Uveitis Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 305761
出版日期 內容資訊 英文 73 Pages
Back to Top
葡萄膜炎治療的全球市場 Global Uveitis Market 2014-2018
出版日期: 2014年05月30日 內容資訊: 英文 73 Pages



第1章 摘要整理

第2章 簡稱一覽

第3章 報告的範圍

  • 市場概要
  • 產品結構

第4章 產品簡介

第5章 市場調查方法

  • 市場調查流程
  • 取材方式

第6章 簡介

第7章 市場環境

  • 市場概要
  • 市場規模及預測
  • 波特的五力分析

第8章 葡萄膜炎治療的選項

第9章 開發平台一瞥

第10章 發病率,患者數

  • 美國
  • 歐洲

第11章 地區的市場區隔

第12章 購買標準

第13章 市場成長推動要素

第14章 推動要素與其影響度

第15章 市場課題

第16章 推動要素及課題的影響度

第17章 市場趨勢

第18章 趨勢與其影響度

第19章 商業環境

  • 競爭情形
    • 重要新聞
    • M&A
  • 市場佔有率分析
  • 其他主要企業

第20章 主要企業分析

第21章 系列內的相關報告

Product Code: IRTNTR3618

About Uveitis

Uveitis is defined as the inflammation of the middle layer of the eye i.e. the uvea, also known as the uceal tract. The uvea consists of the iris, choroid and ciliary body. Infections, injury and autoimmune disorders may be related with the development of uveitis; however, the exact cause is often unknown. Various types of uveitis are: anterior uveitis, intermediate uveitis, posterior uveitis, and pan uveitis. The most common type of uveitis is an inflammation of the iris called iritis (anterior uveitis). Uveitis can be serious, leading to permanent vision loss.

TechNavio's analysts forecast the Global Uveitis market will grow at a CAGR of 26.46 percent over the period 2013-2018.

Covered in this Report

The Global Uveitis market can be segmented into three divisions: the Americas, and the EMEA and APAC regions. To calculate the market size, the report considers the revenue generated from the sales of various therapies used in the treatment of uveitis.

TechNavio's report, the Global Uveitis Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Uveitis market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Abbvie Inc.
  • Alcon Laboratories Inc.
  • Allergan Inc.
  • Bausch & Lomb Inc.

Other Prominent Vendors

  • Artielle ImmunoTherapeutics Inc.
  • Enzo Biochem Inc.
  • Hanall Pharmaceutical Co. Ltd.
  • Lux Biosciences Inc.
  • OphthaliX Inc.
  • Regeneron Pharmaceuticals Inc.
  • TopiVert Ltd.
  • pSivida Corp.
  • XOMA Corp.
  • Santen Pharmaceutical Co.

Key Market Driver

  • Increasing Prevalence of Eye Disorders.

For a full, detailed list, view our report.

Key Market Challenge

  • Unknown Etiology of Uveitis.

For a full, detailed list, view our report.

Key Market Trend

  • Weak Competition in the Uveitis Market.

For a full, detailed list, view our report.

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Product Profiles

05. Market Research Methodology

  • 05.1. Market Research Process
  • 05.2. Research Methodology

06. Introduction

07. Market Landscape

  • 07.1. Market Overview
  • 07.2. Market Size and Forecast
  • 07.3. Five Forces Analysis

08. Treatment Options for Uveitis

09. Pipeline Snapshot

10. Rate of Incidence and Prevalence

  • 10.1.1. US
  • 10.1.2. Europe

11. Geographical Segmentation

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

  • 19.1. Competitive Scenario
    • 19.1.1. Key News
    • 19.1.2. Mergers and Acquisitions
  • 19.2. Market Share Analysis 2013
  • 19.3. Other Prominent Vendors

20. Key Vendor Analysis

21. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Uveitis Market 2013-2018 (US$ billion)
  • Exhibit 3: Off-label Use of Biologic Drugs For the Treatment of Uveitis
  • Exhibit 4: Global Uveitis market by Geographical Segmentation
Back to Top